Table 2.
Year of study | Study population | Sample tested | Test method | Prevalence of MG (total number of sample tested), n (%) |
---|---|---|---|---|
Dhawan et al., 2020[80] | MSMs | FVU Rectal swab Oropharyngeal swab |
PCR | 46 (30.4) |
Rekha et al., 2019[115] | Infertility | Peritonial fluid | PCR | Infertile 162 (6.1) Fertile 162 (0.6) |
Saigal et al., 2016[116] | STIC | Endocervical/urethral swabs, FVU | PCR | 164 (1.2) |
Rajkumari et al., 2015[117] | Infertility | FVU Endocervical swab Endometrium biopsy |
PCR | 100 (16) |
Kokkayil et al., 2013[89] | Infertility | Endocervical swab | PCR | Co-infection of MG and CT in one patient |
Ghosh et al., 2011[118] | HIV population | FVU | PCR | 100 (0) |
Manhas et al., 2009[119] | HIV infected men with NGU | Urine | PCR | HIV positive: 70 (7.1) HIV negative: 30 (3.3) |
STIC=Sexually transmitted infection clinic; FVU=First void urine; PCR=Polymerase chain reaction; MSMs=Men who have sex with mens; MG=Mycoplasma genitalium; CT=Chlamydia trachomatis; NGU=Nongonococcal urethritis; HIV=Human immunodeficiency virus